Drugs Online |
 |
 | ||
|
Diamicron Generic Gliclazide |
|
| ||
Drugs Online » Prescription Drugs 6 » Diamicron Generic Gliclazide Diamicron is used to control bloodglucose in patients with Type 2diabetes. Type 2 diabetes is alsoknown as non-insulin dependentdiabetes mellitus or maturity onsetdiabetes. In Type 2 diabetes bloodglucose stays too high because yourbody is not able to manage itproperly.Diamicron is used when diet andexercise are not enough to controlyour blood glucose.Diamicron can be used alone ortogether with insulin or othermedicines for treating diabetes. Buy Diamicron Generic Gliclazide and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Diamicron Generic Gliclazide: Product Type: Prescription Drugs 6 Diamicron (Generic Gliclazide) Diamicron (Generic Gliclazide) Generic Gliclazide 80mg 200 Tablets 80mg 2 x 200 Tablets 80mg 100 Tablets 80mg 200 Tablets 80mg 400 Tablets Generic Gliclazide Diamicron
View more Prescription Drugs 6 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
